Michaël Sébag
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 79
- Multiple Myeloma Research and Treatments 78
- Oncology 51
- Peptidase Inhibition and Analysis 16
- Cancer Treatment and Pharmacology 13
- Bone health and treatments 8
- CAR-T cell therapy research 7
- Co-authors
- Richard B. Kremer (12 shared papers)David Goltzman (4 shared papers)Johng S. Rhim (3 shared papers)Janet E. Henderson (3 shared papers)Marta Chesi (5 shared papers)Peter Leif Bergsagel (5 shared papers)A. Keith Stewart (3 shared papers)RAFAEL RICARDO AURELIANO DA FONSECA (4 shared papers)
- Journals
- Blood (32 papers)Journal of Medicinal Chemistry (5 papers)European Journal Of Haematology (3 papers)British Journal of Haematology (3 papers)Cancer Cell (3 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Michaël Sébag
104 papers receiving 4.5k citations
Michaël Sébag's Hit Papers
Peers
Comparison fields: 5 of 106
- Hematology 2.6k
- Oncology 1.8k
- Molecular Biology 2.4k
- Genetics 326
- Cancer Research 438
Countries citing papers authored by Michaël Sébag
This map shows the geographic impact of Michaël Sébag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Sébag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Sébag more than expected).
Fields of papers citing papers by Michaël Sébag
This network shows the impact of papers produced by Michaël Sébag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Sébag. The network helps show where Michaël Sébag may publish in the future.
Co-authors
The 25 scholars most cited alongside Michaël Sébag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma Hit paper breakdown → | 2007 | 860 |
| 2 | Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial Hit paper breakdown → | 2016 | 735 |
| 3 | Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study Hit paper breakdown → | 2019 | 516 |
| 4 | 2008 | 314 | |
| 5 | 2012 | 223 | |
| 6 | 2018 | 121 | |
| 7 | 2023 | 114 | |
| 8 | 1991 | 111 | |
| 9 | 1994 | 87 | |
| 10 | Dysregulation of parathyroid hormone-like peptide expression and secretion in a keratinocyte model of tumor progression. | 1991 | 78 |
| 11 | 2020 | 70 | |
| 12 | Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma Hit paper breakdown → | 2025 | 69 |
| 13 | 1996 | 66 | |
| 14 | 2019 | 63 | |
| 15 | 1992 | 60 | |
| 16 | 2008 | 60 | |
| 17 | 1994 | 53 | |
| 18 | 2014 | 53 | |
| 19 | 2012 | 48 | |
| 20 | 2013 | 42 |
About Michaël Sébag
Michaël Sébag is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Infectious Diseases, having authored 113 papers that have together received 4.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (78 papers), Protein Degradation and Inhibitors (40 papers), Peptidase Inhibition and Analysis (16 papers), Cancer Treatment and Pharmacology (13 papers), Bone health and treatments (8 papers), CAR-T cell therapy research (7 papers), HIV/AIDS drug development and treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Hematology (2.6k citations), Oncology (1.8k citations), Molecular Biology (2.4k citations), Genetics (326 citations) and Cancer Research (438 citations). Michaël Sébag has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Richard B. Kremer, David Goltzman, Johng S. Rhim, Janet E. Henderson, Marta Chesi, Peter Leif Bergsagel, A. Keith Stewart, RAFAEL RICARDO AURELIANO DA FONSECA, Rodger Edwin Tiedemann and Wee Joo Chng. Their work appears in journals such as Blood, Journal of Medicinal Chemistry, European Journal Of Haematology, British Journal of Haematology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.